Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Med Virol ; 79(10): 1569-76, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17705168

ABSTRACT

Substantial increase in amantadine-resistant influenza A (H3N2) was reported in Asia and North America in 2005. In this study the frequency and genetic characteristics of amantadine-resistant influenza A, circulated in Japan in 2005-2006 season, were investigated. Isolates were tested by amantadine susceptibility test (TCID(50)/0.2 ml method), and sequencing of the M2 gene to identify mutations that confer resistance. Additionally, the hemagglutinin (HA) and neuraminidase (NA) genes of the viruses were examined. In total, 415 influenza A isolates from six prefectures were screened, and 231 (65.3%) of 354 influenza A (H3N2) were amantadine-resistant, with a serine to asparagine (S31N) change in the M2 gene. However, none of 61 A (H1N1) isolates were resistant. In addition, genetic analyses of the HA gene showed all amantadine-resistant viruses clustered in one (named clade N), possessing specific double mutations at 193, serine to phenylalanine (S193F), and at 225, asparatic acid to asparagine (D225N), and sensitive viruses belonged to another group (clade S). The clinical presentations at the clinical visit did not differ between patients shedding clade N virus and those shedding clade S virus. None of the patients had received previous treatment with amantadine. The results indicate an unusually high prevalence and wide circulation of the amantadine-resistance influenza A (H3N2) in Japan in the 2005-2006 season. These strains had the characteristic double mutations in the HA, in addition to the M2 mutation responsive for resistance. Antiviral resistance monitoring should be intensified and maintained for rapid feedback into treatment strategies, and selection of alternative therapeutic agents.


Subject(s)
Amantadine/pharmacology , Antiviral Agents/pharmacology , Influenza A Virus, H3N2 Subtype/drug effects , Influenza A Virus, H3N2 Subtype/genetics , Influenza, Human/epidemiology , Molecular Epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Amino Acid Substitution , Child , Drug Resistance, Viral , Female , Genes, Viral/genetics , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Humans , Japan/epidemiology , Male , Neuraminidase/genetics , Phylogeny , Point Mutation , Viral Matrix Proteins/genetics , Viral Proteins/genetics
2.
Tohoku J Exp Med ; 210(1): 21-7, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16960341

ABSTRACT

An off-season community influenza outbreak with high prevalence of amantadine-resistant influenza A/H3N2 occurred during September-October 2005 in Nagasaki Prefecture, Japan, prior to standard influenza circulation. A total of 48 patients with influenza-like-illness (ILI) visited a clinic during the outbreak and 27 (69.2%) of 39 ILI patients were positive for influenza A with rapid antigen testing (Quick Vue Rapid SP Influ). Nine patients were not tested because their symptoms were compatible for influenza without examination. Nasopharyngeal swabs were obtained from 4 of 27 rapid test positive patients, and influenza H3N2 strain was isolated from one out of four. The 4 nasopharyngeal samples were positive for influenza A M2 gene in polymerase chain reaction, and sequencing results all showed identical mutation at position 31, serine to asparagine (S31N) in the gene, conferring amantadine resistance. The phylogenetic tree analysis demonstrated that the hemagglutinin (HA) gene sequences of the 4 samples formed a distinct cluster (named clade N) from recent circulating H3N2 strains, characterized by dual mutations at position 193, serine to phenylalanine (S193F), and at position 225, asparatic acid to asparagine (D225N). Our findings suggested that an off-season community influenza outbreak in Nagasaki was caused by a distinct clade in H3N2 (named clade N), which possessed characteristics of amantadine resistance.


Subject(s)
Disease Outbreaks/prevention & control , Influenza A Virus, H3N2 Subtype/genetics , Influenza, Human/epidemiology , Seasons , Acetamides/pharmacology , Acetamides/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Amantadine/pharmacology , Amantadine/therapeutic use , Amino Acid Substitution , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Child , Child, Preschool , Drug Resistance, Viral/genetics , Female , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Humans , Infant , Influenza A Virus, H3N2 Subtype/drug effects , Influenza A Virus, H3N2 Subtype/isolation & purification , Influenza, Human/drug therapy , Japan/epidemiology , Male , Middle Aged , Molecular Sequence Data , Oseltamivir , Phylogeny , Treatment Outcome , Viral Matrix Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL